Verastem (VSTM) Enterprise Value (2011 - 2026)
Verastem's (VSTM) quarterly Enterprise Value came in at -$197.8 million in Q1 2026, down 68.26% year-on-year from -$623.4 million in Q1 2025, and up 3.49% quarter-over-quarter from -$205.0 million in Q4 2025.
Verastem (VSTM) Enterprise Value (2011 - 2026) Analysis & Trends
Verastem's Enterprise Value history runs 16 years deep, the most recent figure standing at -$197.8 million for Q1 2026.
- On a quarterly basis, Enterprise Value fell 68.26% year-over-year to -$197.8 million in Q1 2026; TTM through Mar 2026 was -$197.8 million, a 68.26% decrease from a year earlier, with the FY2025 full-year figure at -$205.0 million, down 130.8% from the prior year.
- Enterprise Value advanced to -$197.8 million in Q1 2026 per VSTM's latest filing, from -$205.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$83.4 million in Q2 2024 and bottomed at -$205.0 million in Q4 2025.
- The 5-year median for Enterprise Value is -$113.2 million (2024), against an average of -$130.1 million.
- Across the five-year window, Enterprise Value surged 54.46% in 2024 and plunged 130.8% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$92.0 million in 2022, then sank by 48.99% to -$137.1 million in 2023, then jumped by 35.23% to -$88.8 million in 2024, then tumbled by 130.8% to -$205.0 million in 2025, then rose by 3.49% to -$197.8 million in 2026.
- Per Business Quant, the three latest VSTM Enterprise Value figures stand at -$197.8 million (Q1 2026), -$205.0 million (Q4 2025), and -$137.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | -197.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -197.83 Mn |
| Dec 31, 2025 | -204.99 Mn |
| Sep 30, 2025 | -137.71 Mn |
| Jun 30, 2025 | -164.32 Mn |
| Mar 31, 2025 | -117.57 Mn |
| Dec 31, 2024 | -88.82 Mn |
| Sep 30, 2024 | -113.18 Mn |
| Jun 30, 2024 | -83.37 Mn |
| Mar 31, 2024 | -110.13 Mn |
| Dec 31, 2023 | -137.13 Mn |
| Sep 30, 2023 | -165.66 Mn |
| Jun 30, 2023 | -183.09 Mn |
| Mar 31, 2023 | -111.20 Mn |
| Dec 31, 2022 | -92.04 Mn |
| Sep 30, 2022 | -103.98 Mn |
| Jun 30, 2022 | -94.31 Mn |
| Mar 31, 2022 | -106.28 Mn |
| Dec 31, 2021 | -153.80 Mn |
| Sep 30, 2021 | -103.42 Mn |
| Jun 30, 2021 | -108.14 Mn |